Max E. Joffe

1.3k total citations
43 papers, 859 citations indexed

About

Max E. Joffe is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Max E. Joffe has authored 43 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 14 papers in Cognitive Neuroscience. Recurrent topics in Max E. Joffe's work include Neuroscience and Neuropharmacology Research (33 papers), Receptor Mechanisms and Signaling (18 papers) and Memory and Neural Mechanisms (12 papers). Max E. Joffe is often cited by papers focused on Neuroscience and Neuropharmacology Research (33 papers), Receptor Mechanisms and Signaling (18 papers) and Memory and Neural Mechanisms (12 papers). Max E. Joffe collaborates with scholars based in United States, Australia and Italy. Max E. Joffe's co-authors include P. Jeffrey Conn, Craig W. Lindsley, Brad A. Grueter, Danny G. Winder, Julie L. Engers, Ferdinando Nicoletti, James Maksymetz, Branden J. Stansley, Carrie A. Grueter and Colleen M. Niswender and has published in prestigious journals such as Neuron, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Max E. Joffe

42 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max E. Joffe United States 19 606 386 272 127 98 43 859
James Maksymetz United States 12 422 0.7× 353 0.9× 162 0.6× 65 0.5× 104 1.1× 13 691
Imane Moutkine France 17 703 1.2× 537 1.4× 160 0.6× 88 0.7× 72 0.7× 26 1.2k
Érika Vigneault Canada 13 285 0.5× 264 0.7× 158 0.6× 74 0.6× 54 0.6× 16 690
Valérie Pasteau France 11 495 0.8× 459 1.2× 107 0.4× 120 0.9× 74 0.8× 12 918
A M Reznik Russia 6 592 1.0× 422 1.1× 146 0.5× 153 1.2× 31 0.3× 30 882
Anthony J. Baucum United States 21 701 1.2× 556 1.4× 197 0.7× 37 0.3× 53 0.5× 42 1.0k
Daniel Paredes United States 16 513 0.8× 359 0.9× 182 0.7× 125 1.0× 132 1.3× 32 1.2k
Ian Fraser United States 14 210 0.3× 228 0.6× 433 1.6× 104 0.8× 45 0.5× 21 1.0k
Taisuke Yoshida Japan 12 234 0.4× 215 0.6× 132 0.5× 162 1.3× 61 0.6× 14 631
Florence Sotty Denmark 20 784 1.3× 468 1.2× 354 1.3× 46 0.4× 62 0.6× 32 1.1k

Countries citing papers authored by Max E. Joffe

Since Specialization
Citations

This map shows the geographic impact of Max E. Joffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max E. Joffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max E. Joffe more than expected).

Fields of papers citing papers by Max E. Joffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max E. Joffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max E. Joffe. The network helps show where Max E. Joffe may publish in the future.

Co-authorship network of co-authors of Max E. Joffe

This figure shows the co-authorship network connecting the top 25 collaborators of Max E. Joffe. A scholar is included among the top collaborators of Max E. Joffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max E. Joffe. Max E. Joffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joffe, Max E., et al.. (2025). Opioid Receptors Modulate Inhibition within the Prefrontal Cortex through Dissociable Cellular and Molecular Mechanisms. Journal of Neuroscience. 45(27). e1963242025–e1963242025.
2.
Moussawi, Khaled, et al.. (2024). Opioid modulation of prefrontal cortex cells and circuits. Neuropharmacology. 248. 109891–109891. 4 indexed citations
3.
4.
Liu, Qi, et al.. (2022). How to design an art-science program? Self-reported benefits for artists and scientists in the VI4 artist-in-residence program. PLoS ONE. 17(12). e0279183–e0279183. 2 indexed citations
5.
Joffe, Max E., Patrick R. Melugin, Samuel W. Centanni, et al.. (2022). Acute restraint stress redirects prefrontal cortex circuit function through mGlu5 receptor plasticity on somatostatin-expressing interneurons. Neuron. 110(6). 1068–1083.e5. 46 indexed citations
6.
Seney, Marianne L., et al.. (2022). Sex differences and hormonal regulation of metabotropic glutamate receptor synaptic plasticity. International review of neurobiology. 168. 311–347. 7 indexed citations
7.
8.
Joffe, Max E., Danny G. Winder, & P. Jeffrey Conn. (2021). Increased Synaptic Strength and mGlu2/3 Receptor Plasticity on Mouse Prefrontal Cortex Intratelencephalic Pyramidal Cells Following Intermittent Access to Ethanol. Alcoholism Clinical and Experimental Research. 45(3). 518–529. 14 indexed citations
9.
Dogra, Shalini, Branden J. Stansley, Zixiu Xiang, et al.. (2021). Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus. Biological Psychiatry. 90(6). 385–398. 36 indexed citations
10.
11.
Joffe, Max E., James Maksymetz, Julie L. Engers, et al.. (2019). mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects. Neuron. 105(1). 46–59.e3. 58 indexed citations
12.
Yohn, Samantha E., Daniel J. Foster, Dan P. Covey, et al.. (2018). Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators. Molecular Psychiatry. 25(11). 2786–2799. 39 indexed citations
13.
Joffe, Max E., Samuel W. Centanni, Anel A. Jaramillo, Danny G. Winder, & P. Jeffrey Conn. (2018). Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies. ACS Chemical Neuroscience. 9(9). 2188–2204. 31 indexed citations
14.
Joffe, Max E., Branden J. Stansley, James Maksymetz, et al.. (2018). Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress. Neuropharmacology. 144. 19–28. 47 indexed citations
15.
Joffe, Max E., et al.. (2018). Genetic loss of GluN2B in D1-expressing cell types enhances long-term cocaine reward and potentiation of thalamo-accumbens synapses. Neuropsychopharmacology. 43(12). 2383–2389. 6 indexed citations
16.
Menna, Luisa Di, Max E. Joffe, Luisa Iacovelli, et al.. (2017). Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system. Neuropharmacology. 128. 301–313. 83 indexed citations
17.
Joffe, Max E., et al.. (2016). GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation. Neuropharmacology. 112(Pt A). 172–180. 14 indexed citations
18.
Joffe, Max E., et al.. (2013). Nuclear Magnetic Resonance Methods for Metabolic Fluxomics. Methods in molecular biology. 985. 335–351. 9 indexed citations
19.
Burns, Christopher J., Emmanuelle Fantino, Andrew K. Powell, et al.. (2011). The Microtubule Depolymerizing Agent CYT997 Causes Extensive Ablation of Tumor Vasculature In Vivo. Journal of Pharmacology and Experimental Therapeutics. 339(3). 799–806. 12 indexed citations
20.
Burns, Christopher J., Michael F. Harte, Xianyong Bu, et al.. (2009). Discovery of CYT997: a structurally novel orally active microtubule targeting agent. Bioorganic & Medicinal Chemistry Letters. 19(16). 4639–4642. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Maksymetz Breakdown of academic impact, for papers by Imane Moutkine Breakdown of academic impact, for papers by Érika Vigneault Breakdown of academic impact, for papers by Valérie Pasteau Breakdown of academic impact, for papers by A M Reznik Breakdown of academic impact, for papers by Anthony J. Baucum Breakdown of academic impact, for papers by Daniel Paredes Breakdown of academic impact, for papers by Ian Fraser Breakdown of academic impact, for papers by Taisuke Yoshida Breakdown of academic impact, for papers by Florence Sotty
Rankless by CCL
2026